Clinical Trials Logo

Unstable Angina clinical trials

View clinical trials related to Unstable Angina.

Filter by:

NCT ID: NCT01637012 Completed - Clinical trials for Myocardial Infarction

Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease

ALEX OCT
Start date: February 2012
Phase: Phase 4
Study type: Interventional

To evaluate the safety and effectiveness of the ALEX stent in a real-world setting of percutaneous coronary interventions in patients with coronary heart disease.

NCT ID: NCT01556126 Completed - Clinical trials for Acute Myocardial Infarction

Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

PARTICIPATE
Start date: February 2012
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate safety and efficacy performances of CRE8 Drug Eluting Stent, in patients comparable to the everyday's clinical practice population, with a specific focus on diabetics, that will be part of a pre-specified study subgroup.

NCT ID: NCT01543373 Completed - Stable Angina Clinical Trials

Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS

DEMONSTRATE
Start date: January 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate the non-inferiority of Cre8 (CID) Drug Eluting Stent, studied 3 months after implant, compared to Vision/Multilink8 Bare Metal Stent (Abbott) studied at 1 month, in terms of neointimal coverage, determined by Optical Coherence Tomography (OCT), as percentage of cross-sections with RUTTS (Ratio of Uncovered to Total Stent Struts Per Cross Section) score ≤ 0.3.

NCT ID: NCT01539603 Completed - Clinical trials for Coronary Artery Disease

Comparison of Drug Eluting Balloon and Drug Eluting Stent

DEBfirst
Start date: April 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Drug-Eluting Balloon first and then bare metal stent compared with drug-eluting stent for treatment of de novo lesions (DEB first).

NCT ID: NCT01522417 Completed - Clinical trials for Myocardial Infarction

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention

SAVI-PCI
Start date: April 2012
Phase: Phase 2
Study type: Interventional

The purpose this study is to assess whether a tirofiban regimen of a high-dose bolus plus a shortened infusion duration compared to label-dosing eptifibatide in patients undergoing percutaneous coronary intervention (PCI) is associated with a non-inferior composite rate of death, PCI-related myocardial infarction, urgent target vessel revascularization or in-hospital major bleeding within 48 hours following PCI or hospital discharge, whichever comes first.

NCT ID: NCT01407146 Completed - Clinical trials for Acute Coronary Syndrome

Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study

Start date: July 2011
Phase:
Study type: Observational

The primary aim of this study is to increase our understanding of care-seeking behavior surrounding heart attacks or acute coronary syndromes [ACS]. This study uses an internet based survey to ask individuals how they obtained medical care in the midst of a heart attack. At present, care-seeking delay among individuals stricken with a heart attack prevents them from obtaining the full therapeutic benefit of hospital based medical care in a timely manner to reduce the long term health consequences of a heart attack. By using a self-tailoring survey instrument the study attempts to take into consideration the complex social processes by which the individual and their family make decisions to seek medical care for symptoms of a heart attack. The study is designed to obtain a national sample of ACS care-seeking behavior in the United States.

NCT ID: NCT01373502 Completed - Stable Angina Clinical Trials

International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions

NEXT
Start date: October 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate non-inferiority in terms of safety and efficacy of DES Limus Carbostent compared to the Taxus Liberté in treating de-novo atherosclerotic lesions in native coronary arteries.

NCT ID: NCT01370278 Completed - Clinical trials for Myocardial Infarction

Clearance Of Mucus In Stents (COMIS)

Start date: June 16, 2011
Phase: N/A
Study type: Interventional

The goal of this clinical research study is to compare the effects of sodium bicarbonate to normal saline when used for clearing mucus blockage in patients with airway stents.

NCT ID: NCT01185899 Completed - Clinical trials for Acute Coronary Syndrome

Usefulness of High-frequency QRS Analysis in the Evaluation of Patients With Chest Pain

Start date: August 2010
Phase: N/A
Study type: Observational

Accurate detection of a heart attack (an acute myocardial infarction) is one of the most pressing needs in medicine. Recordings of the electrocardiogram (ECG) (electrical activity of the heart) are one of the first tools used to diagnose a heart attack, but the ECG is not very accurate, especially at the beginning of a heart attack. A new technique for analysing a special part of the ECG may provide more accurate detection of a heart attack. The study hypothesis is that this new technique, the HFQRS analysis, will provide important additional information to that available from the regular ECG.

NCT ID: NCT01171404 Completed - Clinical trials for Coronary Artery Disease

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

EPICOR
Start date: September 2010
Phase: N/A
Study type: Observational

The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.